Skip to main content
Top
Published in: Seminars in Immunopathology 5/2017

Open Access 01-07-2017 | Review

The meteorology of cytokine storms, and the clinical usefulness of this knowledge

Authors: Ian A. Clark, Bryce Vissel

Published in: Seminars in Immunopathology | Issue 5/2017

Login to get access

Abstract

The term cytokine storm has become a popular descriptor of the dramatic harmful consequences of the rapid release of polypeptide mediators, or cytokines, that generate inflammatory responses. This occurs throughout the body in both non-infectious and infectious disease states, including the central nervous system. In infectious disease it has become a useful concept through which to appreciate that most infectious disease is not caused directly by a pathogen, but by an overexuberant innate immune response by the host to its presence. It is less widely known that in addition to these roles in disease pathogenesis these same cytokines are also the basis of innate immunity, and in lower concentrations have many essential physiological roles. Here we update this field, including what can be learned through the history of how these interlinking three aspects of biology and disease came to be appreciated. We argue that understanding cytokine storms in their various degrees of acuteness, severity and persistence is essential in order to grasp the pathophysiology of many diseases, and thus the basis of newer therapeutic approaches to treating them. This particularly applies to the neurodegenerative diseases.
Literature
3.
go back to reference Ferrara JL (1993) Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 5(5):794–799PubMedCrossRef Ferrara JL (1993) Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol 5(5):794–799PubMedCrossRef
4.
go back to reference Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224(5214):38–42PubMedCrossRef Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224(5214):38–42PubMedCrossRef
5.
go back to reference Kouttab NM, Mehta S, Morgan J, Tannir N, Sahasrabuddhe C, Maizel AL (1984) Lymphokines and monokines as regulators of human lymphoproliferation. Clin Chem 30(9):1539–1545PubMed Kouttab NM, Mehta S, Morgan J, Tannir N, Sahasrabuddhe C, Maizel AL (1984) Lymphokines and monokines as regulators of human lymphoproliferation. Clin Chem 30(9):1539–1545PubMed
6.
go back to reference Jäättelä M (1991) Biologic activities and mechanisms of action of tumor necrosis factor-a cachectin. Lab Investig 64(6):724–742PubMed Jäättelä M (1991) Biologic activities and mechanisms of action of tumor necrosis factor-a cachectin. Lab Investig 64(6):724–742PubMed
7.
go back to reference Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72(9):3666–3670PubMedPubMedCentralCrossRef Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72(9):3666–3670PubMedPubMedCentralCrossRef
8.
go back to reference Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258–267PubMedCrossRef Isaacs A, Lindenmann J (1957) Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258–267PubMedCrossRef
9.
go back to reference Hovanessian AG, La Bonnardiere C, Falcoff E (1980) Action of murine gamma (immune)interferon on beta (fibroblast)-interferon resistant L 1210 and embryonal carcinoma cells. J Interf Res 1(1):125–135CrossRef Hovanessian AG, La Bonnardiere C, Falcoff E (1980) Action of murine gamma (immune)interferon on beta (fibroblast)-interferon resistant L 1210 and embryonal carcinoma cells. J Interf Res 1(1):125–135CrossRef
10.
go back to reference Ruddle NH, Waksman BH (1967) Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity. Science 157(792):1060–1062PubMedCrossRef Ruddle NH, Waksman BH (1967) Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity. Science 157(792):1060–1062PubMedCrossRef
11.
go back to reference Moses HL, Branum EL, Proper JA, Robinson RA (1981) Transforming growth factor production by chemically transformed cells. Cancer Res 41(7):2842–2848PubMed Moses HL, Branum EL, Proper JA, Robinson RA (1981) Transforming growth factor production by chemically transformed cells. Cancer Res 41(7):2842–2848PubMed
12.
go back to reference Aarden LA (1979) Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J Immunol 123:2928–2929 Aarden LA (1979) Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J Immunol 123:2928–2929
13.
go back to reference Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U et al (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147(3):874–882PubMed Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U et al (1991) Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147(3):874–882PubMed
14.
go back to reference Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155(12):5483–5486PubMed Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ (1995) Human IL-17: a novel cytokine derived from T cells. J Immunol 155(12):5483–5486PubMed
16.
go back to reference Pozzolini M, Scarfi S, Mussino F, Ferrando S, Gallus L, Giovine M (2015) Molecular cloning, characterization, and expression analysis of a prolyl 4-hydroxylase from the marine sponge Chondrosia reniformis. Mar Biotechnol (NY) 17(4):393–407. doi:10.1007/s10126-015-9630-3 CrossRef Pozzolini M, Scarfi S, Mussino F, Ferrando S, Gallus L, Giovine M (2015) Molecular cloning, characterization, and expression analysis of a prolyl 4-hydroxylase from the marine sponge Chondrosia reniformis. Mar Biotechnol (NY) 17(4):393–407. doi:10.​1007/​s10126-015-9630-3 CrossRef
18.
go back to reference Beck G, Habicht GS (1986) Isolation and characterization of a primitive interleukin-1-like protein from an invertebrate, Asterias forbesi. Proc Natl Acad Sci U S A 83(19):7429–7433PubMedPubMedCentralCrossRef Beck G, Habicht GS (1986) Isolation and characterization of a primitive interleukin-1-like protein from an invertebrate, Asterias forbesi. Proc Natl Acad Sci U S A 83(19):7429–7433PubMedPubMedCentralCrossRef
19.
go back to reference Wittwer D, Franchini A, Ottaviani E, Wiesner A (1999) Presence of IL-1- and TNF-like molecules in galleria mellonella (Lepidoptera) haemocytes and in an insect cell line Fromestigmene acraea (Lepidoptera). Cytokine 11(9):637–642. doi:10.1006/cyto.1998.0481 PubMedCrossRef Wittwer D, Franchini A, Ottaviani E, Wiesner A (1999) Presence of IL-1- and TNF-like molecules in galleria mellonella (Lepidoptera) haemocytes and in an insect cell line Fromestigmene acraea (Lepidoptera). Cytokine 11(9):637–642. doi:10.​1006/​cyto.​1998.​0481 PubMedCrossRef
22.
go back to reference Wang T, Secombes CJ (2009) Identification and expression analysis of two fish-specific IL-6 cytokine family members, the ciliary neurotrophic factor (CNTF)-like and M17 genes, in rainbow trout Oncorhynchus mykiss. Mol Immunol 46(11–12):2290–2298. doi:10.1016/j.molimm.2009.04.003 PubMedCrossRef Wang T, Secombes CJ (2009) Identification and expression analysis of two fish-specific IL-6 cytokine family members, the ciliary neurotrophic factor (CNTF)-like and M17 genes, in rainbow trout Oncorhynchus mykiss. Mol Immunol 46(11–12):2290–2298. doi:10.​1016/​j.​molimm.​2009.​04.​003 PubMedCrossRef
23.
go back to reference Wang E, Wang J, Long B, Wang K, He Y, Yang Q, Chen D, Geng Y, Huang X, Ouyang P, Lai W (2016) Molecular cloning, expression and the adjuvant effects of interleukin-8 of channel catfish (Ictalurus punctatus) against streptococcus iniae. Sci Rep 6:29310. doi:10.1038/srep29310 PubMedPubMedCentralCrossRef Wang E, Wang J, Long B, Wang K, He Y, Yang Q, Chen D, Geng Y, Huang X, Ouyang P, Lai W (2016) Molecular cloning, expression and the adjuvant effects of interleukin-8 of channel catfish (Ictalurus punctatus) against streptococcus iniae. Sci Rep 6:29310. doi:10.​1038/​srep29310 PubMedPubMedCentralCrossRef
24.
go back to reference Wang T, Husain M, Hong S, Holland JW (2014) Differential expression, modulation and bioactivity of distinct fish IL-12 isoforms: implication towards the evolution of Th1-like immune responses. Eur J Immunol 44(5):1541–1551. doi:10.1002/eji.201344273 PubMedCrossRef Wang T, Husain M, Hong S, Holland JW (2014) Differential expression, modulation and bioactivity of distinct fish IL-12 isoforms: implication towards the evolution of Th1-like immune responses. Eur J Immunol 44(5):1541–1551. doi:10.​1002/​eji.​201344273 PubMedCrossRef
25.
go back to reference Maegraith B (1948) Pathological processes in malaria and Blackwater fever. In. Blackwell, Oxford, pp 367–369 Maegraith B (1948) Pathological processes in malaria and Blackwater fever. In. Blackwell, Oxford, pp 367–369
26.
go back to reference Altschule MD, Freedberg AS, McManus MJ (1945) Circulation and respiration during an episode of chill and fever in man. J Clin Invest 24(6):878–889PubMedCentralCrossRef Altschule MD, Freedberg AS, McManus MJ (1945) Circulation and respiration during an episode of chill and fever in man. J Clin Invest 24(6):878–889PubMedCentralCrossRef
27.
go back to reference Hyman AS (1945) Clinical masquerades of malaria. Observations in South Pacific combat areas. US Naval Medical Bulletin 45:287–308 Hyman AS (1945) Clinical masquerades of malaria. Observations in South Pacific combat areas. US Naval Medical Bulletin 45:287–308
28.
go back to reference Zweifach BW, Benacerraf B, Thomas L (1957) The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. II. The possible role of the reticulo-endothelial system in resistance to each type of shock. J Exp Med 106:403–414PubMedPubMedCentralCrossRef Zweifach BW, Benacerraf B, Thomas L (1957) The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. II. The possible role of the reticulo-endothelial system in resistance to each type of shock. J Exp Med 106:403–414PubMedPubMedCentralCrossRef
29.
go back to reference Zweifach BW, Thomas L (1957) The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. I. Certain similarities between the reactions in normal and endotoxin-tolerant rats. J Exp Med 106(3):385–401PubMedPubMedCentralCrossRef Zweifach BW, Thomas L (1957) The relationship between the vascular manifestations of shock produced by endotoxin, trauma, and hemorrhage. I. Certain similarities between the reactions in normal and endotoxin-tolerant rats. J Exp Med 106(3):385–401PubMedPubMedCentralCrossRef
30.
go back to reference Biozzi G, Benacerraf B, Halpern BN (1955) The effect of Salm. Typhi and its endotoxin on the phagocytic activity of the reticuloendothelial system in mice. Br J Exp Pathol 36(3):226–235PubMedPubMedCentral Biozzi G, Benacerraf B, Halpern BN (1955) The effect of Salm. Typhi and its endotoxin on the phagocytic activity of the reticuloendothelial system in mice. Br J Exp Pathol 36(3):226–235PubMedPubMedCentral
31.
go back to reference Atkins E, Wood WB Jr (1955) Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of typhoid vaccine. J Exp Med 101(5):519–528PubMedPubMedCentralCrossRef Atkins E, Wood WB Jr (1955) Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of typhoid vaccine. J Exp Med 101(5):519–528PubMedPubMedCentralCrossRef
32.
go back to reference Atkins E, Wood WB Jr (1955) Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of typhoid vaccine. J Exp Med 102(5):499–516PubMedPubMedCentralCrossRef Atkins E, Wood WB Jr (1955) Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of typhoid vaccine. J Exp Med 102(5):499–516PubMedPubMedCentralCrossRef
33.
go back to reference Prigal SJ (1961) Development in mice of prolonged non-specific resistance to sarcoma implant and staphylococcus infection following repository injection of lipopolysaccharide. Nature 191:1111–1112PubMedCrossRef Prigal SJ (1961) Development in mice of prolonged non-specific resistance to sarcoma implant and staphylococcus infection following repository injection of lipopolysaccharide. Nature 191:1111–1112PubMedCrossRef
34.
go back to reference Old LJ, Clarke DA, Benacerraf B (1959) Effect of bacillus Calmette Guérin infection on transplanted tumours in the mouse. Nature 184(4682):291–292PubMedCrossRef Old LJ, Clarke DA, Benacerraf B (1959) Effect of bacillus Calmette Guérin infection on transplanted tumours in the mouse. Nature 184(4682):291–292PubMedCrossRef
35.
go back to reference Suter E (1964) Hyperreactivity to endotoxin after infection with BCG. J Immunol 92:49–54PubMed Suter E (1964) Hyperreactivity to endotoxin after infection with BCG. J Immunol 92:49–54PubMed
36.
go back to reference Shands JW Jr, Miller V, Martin H (1969) The hypoglycemic activity of endotoxin. I. Occurrence in animals hyperreactive to endotoxin. Proc Soc Exp Biol Med 130(2):413–417PubMedCrossRef Shands JW Jr, Miller V, Martin H (1969) The hypoglycemic activity of endotoxin. I. Occurrence in animals hyperreactive to endotoxin. Proc Soc Exp Biol Med 130(2):413–417PubMedCrossRef
37.
go back to reference Moore RN, Goodrum KJ, Berry LJ (1976) Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc 19(3):187–197PubMed Moore RN, Goodrum KJ, Berry LJ (1976) Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc 19(3):187–197PubMed
38.
go back to reference Hill MR, Mccallum RE (1992) Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infect Immun 60(10):4040–4050PubMedPubMedCentral Hill MR, Mccallum RE (1992) Identification of tumor necrosis factor as a transcriptional regulator of the phosphoenolpyruvate carboxykinase gene following endotoxin treatment of mice. Infect Immun 60(10):4040–4050PubMedPubMedCentral
39.
go back to reference Sipe JD, Vogel SN, Ryan JL, McAdam KP, Rosenstreich DL (1979) Detection of a mediator derived from endotoxin-stimulated macrophages that induces the acute phase serum amyloid a response in mice. J Exp Med 150(3):597–606PubMedCrossRef Sipe JD, Vogel SN, Ryan JL, McAdam KP, Rosenstreich DL (1979) Detection of a mediator derived from endotoxin-stimulated macrophages that induces the acute phase serum amyloid a response in mice. J Exp Med 150(3):597–606PubMedCrossRef
40.
go back to reference Sztein MB, Vogel SN, Sipe JD, Murphy PA, Mizel SB, Oppenheim JJ, Rosenstreich DL (1981) The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol 63(1):164–176PubMedCrossRef Sztein MB, Vogel SN, Sipe JD, Murphy PA, Mizel SB, Oppenheim JJ, Rosenstreich DL (1981) The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol 63(1):164–176PubMedCrossRef
41.
go back to reference McAdam KP, Li J, Knowles J, Foss NT, Dinarello CA, Rosenwasser LJ, Selinger MJ, Kaplan MM, Goodman R, Herbert PN, Bausserman LL, Nadler LM (1982) The biology of SAA: identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann N Y Acad Sci 389:126–136PubMedCrossRef McAdam KP, Li J, Knowles J, Foss NT, Dinarello CA, Rosenwasser LJ, Selinger MJ, Kaplan MM, Goodman R, Herbert PN, Bausserman LL, Nadler LM (1982) The biology of SAA: identification of the inducer, in vitro synthesis, and heterogeneity demonstrated with monoclonal antibodies. Ann N Y Acad Sci 389:126–136PubMedCrossRef
43.
go back to reference Janeway CA Jr (1989) Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54(9):1–13PubMedCrossRef Janeway CA Jr (1989) Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54(9):1–13PubMedCrossRef
44.
45.
go back to reference Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 24(3):340–355PubMedCrossRef Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 24(3):340–355PubMedCrossRef
46.
go back to reference Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162(7):3749–3752PubMed Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S (1999) Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162(7):3749–3752PubMed
47.
go back to reference Tovey MG (1988) The expression of cytokines in the organs of normal individuals: role in homeostasis. A review. J Biol Regul Homeost Agents 2(2):87–92PubMed Tovey MG (1988) The expression of cytokines in the organs of normal individuals: role in homeostasis. A review. J Biol Regul Homeost Agents 2(2):87–92PubMed
48.
go back to reference Clark IA, Chaudhri G (1988) Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 70(1):99–103PubMedCrossRef Clark IA, Chaudhri G (1988) Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol 70(1):99–103PubMedCrossRef
51.
go back to reference Sanchez-Alcazar JA, Schneider E, Martinez MA, Carmona P, Hernandez-Munoz I, Siles E, De la Torre P, Ruiz-Cabello J, Garcia I, Solis-Herruzo JA (2000) Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 275(18):13353–13361PubMedCrossRef Sanchez-Alcazar JA, Schneider E, Martinez MA, Carmona P, Hernandez-Munoz I, Siles E, De la Torre P, Ruiz-Cabello J, Garcia I, Solis-Herruzo JA (2000) Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J Biol Chem 275(18):13353–13361PubMedCrossRef
52.
go back to reference Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B (2012) Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales. Pharmacol Rev 64(4):1004–1026. doi:10.1124/pr.112.005850 PubMedCrossRef Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B (2012) Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales. Pharmacol Rev 64(4):1004–1026. doi:10.​1124/​pr.​112.​005850 PubMedCrossRef
53.
go back to reference Oppenheim JJ, Lew W, Akahoshi T, Matsushima K, Neta R (1988) Aspects of cytokine induced modulation of immunity and inflammation with emphasis on interleukin 1. Arzneimittel - Forschung/Drug Research 38(3A):461–465PubMed Oppenheim JJ, Lew W, Akahoshi T, Matsushima K, Neta R (1988) Aspects of cytokine induced modulation of immunity and inflammation with emphasis on interleukin 1. Arzneimittel - Forschung/Drug Research 38(3A):461–465PubMed
54.
go back to reference Clark IA (2007) How TNF was recognized to be a key mechanism of disease. Cytokine Growth FR 18:335–343CrossRef Clark IA (2007) How TNF was recognized to be a key mechanism of disease. Cytokine Growth FR 18:335–343CrossRef
55.
go back to reference Clark IA, Richmond JE, Wills EJ, Allison AC (1977) Intra-erythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology 75(2):189–196PubMedCrossRef Clark IA, Richmond JE, Wills EJ, Allison AC (1977) Intra-erythrocytic death of the parasite in mice recovering from infection with Babesia microti. Parasitology 75(2):189–196PubMedCrossRef
56.
go back to reference Clark IA, Wills EJ, Richmond JE, Allison AC (1977) Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect Immun 17(2):430–438PubMedPubMedCentral Clark IA, Wills EJ, Richmond JE, Allison AC (1977) Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition. Infect Immun 17(2):430–438PubMedPubMedCentral
57.
go back to reference Clark IA (1978) Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet ii 8080:75–77CrossRef Clark IA (1978) Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet ii 8080:75–77CrossRef
58.
go back to reference Clark IA, Virelizier J-L, Carswell EA, Wood PR (1981) Possible importance of macrophage-derived mediators in acute malaria. Infect Immun 32(3):1058–1066PubMedPubMedCentral Clark IA, Virelizier J-L, Carswell EA, Wood PR (1981) Possible importance of macrophage-derived mediators in acute malaria. Infect Immun 32(3):1058–1066PubMedPubMedCentral
59.
go back to reference Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985) Human tumor necrosis factor: production, purification, and characterization. J Biol Chem 260(4):2345–2354PubMed Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henzel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985) Human tumor necrosis factor: production, purification, and characterization. J Biol Chem 260(4):2345–2354PubMed
60.
go back to reference Spriggs DR, Sherman ML, Kufe DW, Frei E (1987) Tumour necrosis factor: clinical trials and future directions. In: Tumour Necrosis Factor and Related Cytokines, Ciba Foundation Symposium, John Wiley and Sons, Chichester, pp 206–227 Spriggs DR, Sherman ML, Kufe DW, Frei E (1987) Tumour necrosis factor: clinical trials and future directions. In: Tumour Necrosis Factor and Related Cytokines, Ciba Foundation Symposium, John Wiley and Sons, Chichester, pp 206–227
61.
go back to reference Spriggs DR, Sherman ML, Michie H, Arthur KA, Imamura K, Wilmore D, Frei E, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. J Natl Cancer Inst 80:1039–1044PubMedCrossRef Spriggs DR, Sherman ML, Michie H, Arthur KA, Imamura K, Wilmore D, Frei E, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. J Natl Cancer Inst 80:1039–1044PubMedCrossRef
62.
go back to reference Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei EF, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase 1 toxicity and effects on lipid metabolism. J Clin Oncol 6:344–350PubMedCrossRef Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei EF, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase 1 toxicity and effects on lipid metabolism. J Clin Oncol 6:344–350PubMedCrossRef
63.
go back to reference Demetri GD, Spriggs DR, Sherman ML, Arthur KA, Imamura K, Kufe DW (1989) A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo. J Clin Oncol 7(10):1545–1553PubMedCrossRef Demetri GD, Spriggs DR, Sherman ML, Arthur KA, Imamura K, Kufe DW (1989) A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo. J Clin Oncol 7(10):1545–1553PubMedCrossRef
64.
go back to reference Clark IA (1982) Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr 60(14):756–758PubMedCrossRef Clark IA (1982) Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr 60(14):756–758PubMedCrossRef
65.
go back to reference Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234(4775):470–474PubMedCrossRef Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234(4775):470–474PubMedCrossRef
66.
go back to reference Clark IA, Cowden WB, Butcher GA, Hunt NH (1987) Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol 129(1):192–199PubMedPubMedCentral Clark IA, Cowden WB, Butcher GA, Hunt NH (1987) Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol 129(1):192–199PubMedPubMedCentral
67.
go back to reference Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12(2):123–137PubMedCrossRef Hart BL (1988) Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 12(2):123–137PubMedCrossRef
68.
go back to reference Clark IA, Budd AC, Alleva LM (2008) Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma. Malar J 7:208PubMedPubMedCentralCrossRef Clark IA, Budd AC, Alleva LM (2008) Sickness behaviour pushed too far--the basis of the syndrome seen in severe protozoal, bacterial and viral diseases and post-trauma. Malar J 7:208PubMedPubMedCentralCrossRef
69.
go back to reference Bermudez LE, Young LS (1988) TNF, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium Complex. J Immunol 140(9):3006–3013PubMed Bermudez LE, Young LS (1988) TNF, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium Complex. J Immunol 140(9):3006–3013PubMed
71.
go back to reference Zhan YF, Liu ZQ, Cheers C (1996) Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 64(7):2782–2786PubMedPubMedCentral Zhan YF, Liu ZQ, Cheers C (1996) Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 64(7):2782–2786PubMedPubMedCentral
72.
go back to reference Ahmed K, Al Matrouk KA, Martinez G, Oishi K, Rotimi VO, Nagatake T (1999) Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. AmJTrop Med Hyg 61(3):425–427CrossRef Ahmed K, Al Matrouk KA, Martinez G, Oishi K, Rotimi VO, Nagatake T (1999) Increased serum levels of interferon-gamma and interleukin-12 during human brucellosis. AmJTrop Med Hyg 61(3):425–427CrossRef
73.
go back to reference Degre M, Bukholm G (1990) Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model. J Biol Regul Homeost Agents 4(4):157–161PubMed Degre M, Bukholm G (1990) Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model. J Biol Regul Homeost Agents 4(4):157–161PubMed
74.
go back to reference Bhutta ZA, Mansoorali N, Hussain R (1997) Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome. J Inf Secur 35(3):253–256 Bhutta ZA, Mansoorali N, Hussain R (1997) Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome. J Inf Secur 35(3):253–256
75.
go back to reference Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor-1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364(6440):798–802PubMedCrossRef Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H (1993) Mice lacking the tumour necrosis factor receptor-1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364(6440):798–802PubMedCrossRef
76.
go back to reference Nakane M, Klinghofer V, Kuk JE, Donnelly JL, Budzik GP, Pollock JS, Basha F, Carter GW (1995) Novel potent and selective inhibitors of inducible nitric oxide synthase. Molec Pharmacol 47(4):831–834 Nakane M, Klinghofer V, Kuk JE, Donnelly JL, Budzik GP, Pollock JS, Basha F, Carter GW (1995) Novel potent and selective inhibitors of inducible nitric oxide synthase. Molec Pharmacol 47(4):831–834
77.
go back to reference Titus RG, Sherry B, Cerami A (1989) Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 170:2097–2104PubMedCrossRef Titus RG, Sherry B, Cerami A (1989) Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J Exp Med 170:2097–2104PubMedCrossRef
78.
go back to reference Raziuddin S, Abdalla RE, el Awad EH, al Janadi M (1994) Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. J Infect Dis 170(4):1037–1040PubMedCrossRef Raziuddin S, Abdalla RE, el Awad EH, al Janadi M (1994) Immunoregulatory and proinflammatory cytokine production in visceral and cutaneous leishmaniasis. J Infect Dis 170(4):1037–1040PubMedCrossRef
79.
go back to reference Chang HR, Grau GE, Perchere JC (1990) Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunol 69:33–37 Chang HR, Grau GE, Perchere JC (1990) Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunol 69:33–37
80.
go back to reference Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG (1997) Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Phys 272(5):E908–E917 Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG (1997) Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Phys 272(5):E908–E917
81.
go back to reference Sladkova T, Kostolansky F (2006) The role of cytokines in the immune response to influenza a virus infection. Acta Virol 50(3):151–162PubMed Sladkova T, Kostolansky F (2006) The role of cytokines in the immune response to influenza a virus infection. Acta Virol 50(3):151–162PubMed
83.
go back to reference Clark IA (1987) Cell-mediated immunity in protection and pathology of malaria. Parasitol Today 3(10):300–305PubMedCrossRef Clark IA (1987) Cell-mediated immunity in protection and pathology of malaria. Parasitol Today 3(10):300–305PubMedCrossRef
84.
go back to reference Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50(6):693–703PubMedCrossRef Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50(6):693–703PubMedCrossRef
86.
go back to reference Cereghini S (1996) Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10(2):267–282PubMed Cereghini S (1996) Liver-enriched transcription factors and hepatocyte differentiation. FASEB J 10(2):267–282PubMed
87.
go back to reference Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A (2007) TNF alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci U S A 104(31):12843–12848PubMedPubMedCentralCrossRef Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A (2007) TNF alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci U S A 104(31):12843–12848PubMedPubMedCentralCrossRef
88.
go back to reference Perlmutter DH, Dinarello CA, Punsal PI, Colten HR (1986) Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 78(5):1349–1354PubMedPubMedCentralCrossRef Perlmutter DH, Dinarello CA, Punsal PI, Colten HR (1986) Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 78(5):1349–1354PubMedPubMedCentralCrossRef
89.
go back to reference Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL (1998) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780(2):294–303PubMedCrossRef Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk GL (1998) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res 780(2):294–303PubMedCrossRef
90.
go back to reference Qin B, Qiu W, Avramoglu RK, Adeli K (2007) Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 56(2):450–461PubMedCrossRef Qin B, Qiu W, Avramoglu RK, Adeli K (2007) Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes 56(2):450–461PubMedCrossRef
91.
go back to reference Steinshamn S, Waage A (2000) Lack of endotoxin tolerance with respect to TNF alpha production in the subarachnoid space. APMIS 108(2):107–112PubMedCrossRef Steinshamn S, Waage A (2000) Lack of endotoxin tolerance with respect to TNF alpha production in the subarachnoid space. APMIS 108(2):107–112PubMedCrossRef
92.
go back to reference Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB (2000) Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 55(7):1052–1054PubMedCrossRef Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, Jones T, Kreutzberg GW, Banati RB (2000) Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology 55(7):1052–1054PubMedCrossRef
93.
go back to reference Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, Sharp DJ (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70(3):374–383. doi:10.1002/ana.22455 PubMedCrossRef Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA, Gunanayagam K, Gelosa G, Sharp DJ (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70(3):374–383. doi:10.​1002/​ana.​22455 PubMedCrossRef
96.
go back to reference Liu T, Clark RK, Mcdonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25(7):1481–1488PubMedCrossRef Liu T, Clark RK, Mcdonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25(7):1481–1488PubMedCrossRef
97.
go back to reference Patel A, Siegel A, Zalcman SS (2010) Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 24(8):1276–1280PubMedPubMedCentralCrossRef Patel A, Siegel A, Zalcman SS (2010) Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 24(8):1276–1280PubMedPubMedCentralCrossRef
103.
go back to reference Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90(5):663–670PubMedCrossRef Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90(5):663–670PubMedCrossRef
104.
go back to reference Ferguson AR, Christensen RN, Gensel JC, Miller BA, Sun F, Beattie EC, Bresnahan JC, Beattie MS (2008) Cell death after spinal cord injury is exacerbated by rapid TNFalpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 28(44):11391–11400PubMedPubMedCentralCrossRef Ferguson AR, Christensen RN, Gensel JC, Miller BA, Sun F, Beattie EC, Bresnahan JC, Beattie MS (2008) Cell death after spinal cord injury is exacerbated by rapid TNFalpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J Neurosci 28(44):11391–11400PubMedPubMedCentralCrossRef
105.
go back to reference Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087):1054–1059PubMedCrossRef Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-alpha. Nature 440(7087):1054–1059PubMedCrossRef
106.
go back to reference Cumiskey D, Butler MP, Moynagh PN, O'Connor JJ (2007) Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Res 1136(1):13–19PubMedCrossRef Cumiskey D, Butler MP, Moynagh PN, O'Connor JJ (2007) Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation. Brain Res 1136(1):13–19PubMedCrossRef
107.
go back to reference Bernardino L, Agasse F, Silva B, Ferreira R, Grade S, Malva JO (2008) Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 26(9):2361–2371PubMedCrossRef Bernardino L, Agasse F, Silva B, Ferreira R, Grade S, Malva JO (2008) Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 26(9):2361–2371PubMedCrossRef
108.
go back to reference Park KM, Yule DI, Bowers WJ (2008) Tumor necrosis factor-alpha potentiates intraneuronal CA2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 283:33069–33079PubMedPubMedCentralCrossRef Park KM, Yule DI, Bowers WJ (2008) Tumor necrosis factor-alpha potentiates intraneuronal CA2+ signaling via regulation of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 283:33069–33079PubMedPubMedCentralCrossRef
111.
go back to reference Allan SM, Lawrence CB, Rothwell NJ (1998) Interleukin-1 beta and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes. Mol Psychiatry 3(2):178–182PubMedCrossRef Allan SM, Lawrence CB, Rothwell NJ (1998) Interleukin-1 beta and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes. Mol Psychiatry 3(2):178–182PubMedCrossRef
112.
go back to reference Sommer C, Lindenlaub T, Teuteberg P, Schafers M, Hartung T, Toyka KV (2001) Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 913(1):86–89PubMedCrossRef Sommer C, Lindenlaub T, Teuteberg P, Schafers M, Hartung T, Toyka KV (2001) Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 913(1):86–89PubMedCrossRef
113.
go back to reference Liu Y, Liu F, Grundke Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225(1):54–62PubMedPubMedCentralCrossRef Liu Y, Liu F, Grundke Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225(1):54–62PubMedPubMedCentralCrossRef
114.
go back to reference Clark IA, Alleva LM, Vissel B (2010) The roles of TNF in brain dysfunction and disease. Pharmacol Ther 128:519–548PubMedCrossRef Clark IA, Alleva LM, Vissel B (2010) The roles of TNF in brain dysfunction and disease. Pharmacol Ther 128:519–548PubMedCrossRef
115.
go back to reference Clark IA, Alleva LM (2009) Is human malarial coma caused, or merely deepened, by sequestration? Trends Parasitol 25(7):314–318PubMedCrossRef Clark IA, Alleva LM (2009) Is human malarial coma caused, or merely deepened, by sequestration? Trends Parasitol 25(7):314–318PubMedCrossRef
116.
go back to reference Gordon GR, Baimoukhametova DV, Hewitt SA, Rajapaksha WR, Fisher TE, Bains JS (2005) Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci 8(8):1078–1086PubMedCrossRef Gordon GR, Baimoukhametova DV, Hewitt SA, Rajapaksha WR, Fisher TE, Bains JS (2005) Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat Neurosci 8(8):1078–1086PubMedCrossRef
118.
go back to reference Acosta SA, Tajiri N, Sanberg PR, Kaneko Y, Borlongan CV (2016) Increased amyloid precursor protein and tau expression manifests as key secondary cell death in chronic traumatic brain injury. J Cell Physiol. doi:10.1002/jcp.25629 PubMed Acosta SA, Tajiri N, Sanberg PR, Kaneko Y, Borlongan CV (2016) Increased amyloid precursor protein and tau expression manifests as key secondary cell death in chronic traumatic brain injury. J Cell Physiol. doi:10.​1002/​jcp.​25629 PubMed
119.
go back to reference Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146(2):176–178PubMedCrossRef Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F (1992) Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 146(2):176–178PubMedCrossRef
120.
go back to reference Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R (2007) Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 35(Pt 5):1219–1223PubMedCrossRef Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R (2007) Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 35(Pt 5):1219–1223PubMedCrossRef
121.
go back to reference Beutler B, Poltorak A (2001) Sepsis and evolution of the innate immune response. Crit Care Med 29(7 Suppl S):S2–S6PubMedCrossRef Beutler B, Poltorak A (2001) Sepsis and evolution of the innate immune response. Crit Care Med 29(7 Suppl S):S2–S6PubMedCrossRef
122.
go back to reference Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2011(2):e167CrossRef Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2011(2):e167CrossRef
123.
124.
go back to reference Clark IA, Alleva LM, Vissel B (2011) TNF and leptin tell essentially the same story in Alzheimer's disease. J Alzheimers Dis 26(2):201–205PubMed Clark IA, Alleva LM, Vissel B (2011) TNF and leptin tell essentially the same story in Alzheimer's disease. J Alzheimers Dis 26(2):201–205PubMed
130.
go back to reference Wang QW, Wu JQ, Rowan MJ, Anwyl R (2005) Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur J Neurosci 22(11):2827–2832PubMedCrossRef Wang QW, Wu JQ, Rowan MJ, Anwyl R (2005) Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur J Neurosci 22(11):2827–2832PubMedCrossRef
131.
go back to reference Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229(4716):869–871PubMedCrossRef Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 229(4716):869–871PubMedCrossRef
132.
go back to reference Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal shock bacteraemia. Nature 330(6149):662–664PubMedCrossRef Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal shock bacteraemia. Nature 330(6149):662–664PubMedCrossRef
133.
go back to reference Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA (1996) Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 335(5):311–315PubMedCrossRef Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA (1996) Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 335(5):311–315PubMedCrossRef
134.
go back to reference Abraham E, Anzueto A, Gutierrez G, Tessler S, Sanpedro G, Wunderink R, Dalnogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 351(9107):929–933PubMedCrossRef Abraham E, Anzueto A, Gutierrez G, Tessler S, Sanpedro G, Wunderink R, Dalnogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet 351(9107):929–933PubMedCrossRef
135.
go back to reference Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098–1104. doi:10.1056/NEJMoa011110 PubMedCrossRef Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345(15):1098–1104. doi:10.​1056/​NEJMoa011110 PubMedCrossRef
137.
go back to reference Tobinick EL, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer's disease: a 6- month pilot study. MedGenMed Neurol Neurosurg 8(2):25 Tobinick EL, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer's disease: a 6- month pilot study. MedGenMed Neurol Neurosurg 8(2):25
138.
go back to reference Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V (2012) Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 26(12):1051–1070. doi:10.1007/s40263-012-0013-2 PubMedCrossRef Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, DePuy V (2012) Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs 26(12):1051–1070. doi:10.​1007/​s40263-012-0013-2 PubMedCrossRef
142.
go back to reference Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, Kim AS, Johnson JN, Bates D, King B, Case C, McGrogan M, Yankee EW, Schwartz NE (2016) Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study. Stroke 47(7):1817–1824. doi:10.1161/strokeaha.116.012995 PubMedCrossRef Steinberg GK, Kondziolka D, Wechsler LR, Lunsford LD, Coburn ML, Billigen JB, Kim AS, Johnson JN, Bates D, King B, Case C, McGrogan M, Yankee EW, Schwartz NE (2016) Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1/2a study. Stroke 47(7):1817–1824. doi:10.​1161/​strokeaha.​116.​012995 PubMedCrossRef
143.
go back to reference Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-I. J Exp Med 163:1433–1450PubMedCrossRef Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, O'Connor JV (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-I. J Exp Med 163:1433–1450PubMedCrossRef
144.
go back to reference Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H et al (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344(8930):1105–1110PubMedCrossRef Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H et al (1994) Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344(8930):1105–1110PubMedCrossRef
145.
go back to reference Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2(8657):244–247PubMedCrossRef Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2(8657):244–247PubMedCrossRef
146.
go back to reference Butler DM, Maini RN, Feldmann M, Brennan FM (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6(4):225–230PubMed Butler DM, Maini RN, Feldmann M, Brennan FM (1995) Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Eur Cytokine Netw 6(4):225–230PubMed
147.
go back to reference Lorenz HM, Antoni C, Valerius T, Repp R, Grunke M, Schwerdtner N, Nusslein H, Woody J, Kalden JR, Manger B (1996) In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 156(4):1646–1653PubMed Lorenz HM, Antoni C, Valerius T, Repp R, Grunke M, Schwerdtner N, Nusslein H, Woody J, Kalden JR, Manger B (1996) In vivo blockade of TNF-alpha by intravenous infusion of a chimeric monoclonal TNF-alpha antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 156(4):1646–1653PubMed
148.
go back to reference Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN (1999) Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163(3):1521–1528PubMed Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, Breedveld FC, Smolen JS, Eberl G, deWoody K, Feldmann M, Maini RN (1999) Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163(3):1521–1528PubMed
150.
go back to reference Le JM, Weinstein D, Gubler U, Vilcek J (1987) Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol 138(7):2137–2142PubMed Le JM, Weinstein D, Gubler U, Vilcek J (1987) Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. J Immunol 138(7):2137–2142PubMed
151.
go back to reference Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163(6):1363–1375PubMedCrossRef Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D (1986) Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med 163(6):1363–1375PubMedCrossRef
152.
go back to reference Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323(6083):86–89. doi:10.1038/323086a0 PubMedCrossRef Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323(6083):86–89. doi:10.​1038/​323086a0 PubMedCrossRef
153.
go back to reference Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987) Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138(5):1464–1468PubMed Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM (1987) Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138(5):1464–1468PubMed
154.
go back to reference Elias JA, Gustilo K, Freundlich B (1988) Human alveolar macrophage and blood monocyte inhibition of fibroblast proliferation. Evidence for synergy between interleukin-1 and tumor necrosis factor. Am Rev Respir Dis 138(6):1595–1603. doi:10.1164/ajrccm/138.6.1595 PubMedCrossRef Elias JA, Gustilo K, Freundlich B (1988) Human alveolar macrophage and blood monocyte inhibition of fibroblast proliferation. Evidence for synergy between interleukin-1 and tumor necrosis factor. Am Rev Respir Dis 138(6):1595–1603. doi:10.​1164/​ajrccm/​138.​6.​1595 PubMedCrossRef
155.
go back to reference Ogawa H, Nielsen S, Kawakami M (1989) Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1003(2):131–135PubMedCrossRef Ogawa H, Nielsen S, Kawakami M (1989) Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1003(2):131–135PubMedCrossRef
156.
go back to reference Bluthe RM, Pawlowski M, Suarez S, Parnet P, Pittman Q, Kelley KW, Dantzer R (1994) Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19(2):197–207PubMedCrossRef Bluthe RM, Pawlowski M, Suarez S, Parnet P, Pittman Q, Kelley KW, Dantzer R (1994) Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology 19(2):197–207PubMedCrossRef
157.
go back to reference Rockett KA, Awburn MM, Rockett EJ, Clark IA (1994) Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. AmJTrop Med Hyg 50(6):735–742CrossRef Rockett KA, Awburn MM, Rockett EJ, Clark IA (1994) Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. AmJTrop Med Hyg 50(6):735–742CrossRef
159.
go back to reference Goh AX, Bertin-Maghit S, Ping Yeo S, Ho AW, Derks H, Mortellaro A, Wang CI (2014) A novel human anti-interleukin-1beta neutralizing monoclonal antibody showing in vivo efficacy. MAbs 6(3):765–773. doi:10.4161/mabs.28614 PubMedCrossRef Goh AX, Bertin-Maghit S, Ping Yeo S, Ho AW, Derks H, Mortellaro A, Wang CI (2014) A novel human anti-interleukin-1beta neutralizing monoclonal antibody showing in vivo efficacy. MAbs 6(3):765–773. doi:10.​4161/​mabs.​28614 PubMedCrossRef
160.
go back to reference Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR (1987) A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139(5):1546–1549PubMed Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR (1987) A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol 139(5):1546–1549PubMed
165.
go back to reference Galea J, Ogungbenro K, Hulme S, Greenhalgh A, Aarons L, Scarth S, Hutchinson P, Grainger S, King A, Hopkins SJ, Rothwell N, Tyrrell P (2011) Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab 31(2):439–447. doi:10.1038/jcbfm.2010.103 PubMedCrossRef Galea J, Ogungbenro K, Hulme S, Greenhalgh A, Aarons L, Scarth S, Hutchinson P, Grainger S, King A, Hopkins SJ, Rothwell N, Tyrrell P (2011) Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab 31(2):439–447. doi:10.​1038/​jcbfm.​2010.​103 PubMedCrossRef
166.
go back to reference Singh N, Hopkins SJ, Hulme S, Galea JP, Hoadley M, Vail A, Hutchinson PJ, Grainger S, Rothwell NJ, King AT, Tyrrell PJ (2014) The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J Neuroinflammation 11:1. doi:10.1186/1742-2094-11-1 PubMedPubMedCentralCrossRef Singh N, Hopkins SJ, Hulme S, Galea JP, Hoadley M, Vail A, Hutchinson PJ, Grainger S, Rothwell NJ, King AT, Tyrrell PJ (2014) The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J Neuroinflammation 11:1. doi:10.​1186/​1742-2094-11-1 PubMedPubMedCentralCrossRef
167.
go back to reference Savman K, Blennow M, Hagberg H, Tarkowski E, Thoresen M, Whitelaw A (2002) Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta paediatrica (Oslo, Norway : 1992) 91(12):1357–1363CrossRef Savman K, Blennow M, Hagberg H, Tarkowski E, Thoresen M, Whitelaw A (2002) Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta paediatrica (Oslo, Norway : 1992) 91(12):1357–1363CrossRef
168.
go back to reference Rajatileka S, Odd D, Robinson MT, Spittle AC, Dwomoh L, Williams M, Harding D, Wagstaff M, Owen M, Crosby C, Ching J, Molnar E, Luyt K, Varadi A (2017) Variants of the EAAT2 glutamate transporter Gene promoter are associated with cerebral palsy in preterm infants. Mol Neurobiol. doi:10.1007/s12035-017-0462-1 PubMed Rajatileka S, Odd D, Robinson MT, Spittle AC, Dwomoh L, Williams M, Harding D, Wagstaff M, Owen M, Crosby C, Ching J, Molnar E, Luyt K, Varadi A (2017) Variants of the EAAT2 glutamate transporter Gene promoter are associated with cerebral palsy in preterm infants. Mol Neurobiol. doi:10.​1007/​s12035-017-0462-1 PubMed
Metadata
Title
The meteorology of cytokine storms, and the clinical usefulness of this knowledge
Authors
Ian A. Clark
Bryce Vissel
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Seminars in Immunopathology / Issue 5/2017
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-017-0628-y

Other articles of this Issue 5/2017

Seminars in Immunopathology 5/2017 Go to the issue